Literature DB >> 29476759

Synthesis and biological evaluation of estrone 3-O-ether derivatives containing the piperazine moiety.

Hong Chen1, Xue Liang2, Tao Sun1, Xiaoguang Qiao1, Zhou Zhan1, Ziyong Li1, Chaojun He1, Huiyuan Ya3, Mu Yuan4.   

Abstract

A series of new estrone derivatives were designed and synthesized, and their structures were confirmed by spectroscopic methods. All new estrone derivatives were investigated for their in vitro cytotoxic efficacies against a panel of three human prostate cancer cell lines (PC-3, LNCaP, and DU145). The derivatives 6, 7, 10, 15, 16, 20, 21, 22, 24 and 26 showed important cytotoxic actions against individual carcinoma cell line collections. Moreover, antagonistic activities of compounds (7, 15, 16 and 21) towards a1-ARs (α1A, α1B, and α1D) were further evaluated using dual-luciferase reporter assays, and the compounds 16 and 21 exhibited better a1-ARs subtype selectivity. The structure-activity relationship (SAR) suggested that the substitute's type and position on the phenyl group leads to the interesting variations within pharmacological effects of resultant molecular systems.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Estrone derivatives; Piperazines; Prostate cancer; Structure-activity relationship; Synthesis

Mesh:

Substances:

Year:  2018        PMID: 29476759     DOI: 10.1016/j.steroids.2018.02.002

Source DB:  PubMed          Journal:  Steroids        ISSN: 0039-128X            Impact factor:   2.668


  2 in total

1.  Synthesis, bioactivity, and molecular docking of novel arylpiperazine derivatives as potential AR antagonists.

Authors:  Yueheng Qi; Hong Chen; Shijin Chen; Jianliang Shen; Jingguo Li
Journal:  Front Chem       Date:  2022-08-15       Impact factor: 5.545

2.  Self-assembly of new cobalt complexes based on [Co (SCN)4], synthesis, empirical, antioxidant activity, and quantum theory investigations.

Authors:  Amal Ferchichi; Jawher Makhlouf; Youness El Bakri; Kandasamy Saravanan; Arto Valkonen; Heba E Hashem; Sajjad Ahmad; Wajda Smirani
Journal:  Sci Rep       Date:  2022-09-22       Impact factor: 4.996

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.